Stock Events

Stock Events

Moberg Pharma AB 

$0
10
+$0+0% Monday 00:00

Statistics

Day High
-
Day Low
-
52W High
-
52W Low
-
Volume
-
Avg. Volume
-
Mkt Cap
0
P/E Ratio
0
Dividend Yield
-
Dividend
-

Dividends

0%Dividend Yield
Nov 19
$4.84
10Y Growth
N/A
5Y Growth
N/A
3Y Growth
N/A
1Y Growth
N/A

Earnings

31DecExpected
Q1 2019
Q2 2019
Q3 2019
Q4 2019
Q1 2020
Q2 2020
Q3 2020
-0.05
0.03
0.1
0.18
Expected EPS
0
Actual EPS
-0.0365

People Also Follow

This list is based on the watchlists of people on Stock Events who follow MBGRF. It's not an investment recommendation.
Alphabet
79493
GOOGL
Apple
69146
AAPL
Microsoft
64576
MSFT
Amazon
60260
AMZN

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Johnson & Johnson
JNJ
Mkt Cap455.04B
Johnson & Johnson operates in the pharmaceuticals sector, offering a wide range of healthcare products that compete with Moberg Pharma's offerings.
Pfizer
PFE
Mkt Cap140.15B
Pfizer is a global biopharmaceutical company with a portfolio that includes treatments in areas similar to those targeted by Moberg Pharma.
Novartis
NVS
Mkt Cap237.61B
Novartis is a multinational pharmaceutical company that produces drugs in many of the same categories as Moberg Pharma.
GSK
GSK
Mkt Cap94.51B
GlaxoSmithKline is a healthcare company that develops and markets drugs and vaccines in various areas, including those competing with Moberg Pharma.
Merck
MRK
Mkt Cap214.76B
Merck & Co., Inc. is a global healthcare company that offers products in areas that overlap with Moberg Pharma's therapeutic focus.
Abbvie
ABBV
Mkt Cap385.18B
AbbVie is a biopharmaceutical company with a broad range of medical products that compete in the same market as Moberg Pharma.
Sanofi
SNY
Mkt Cap124.45B
Sanofi is a global healthcare leader that offers drugs in many of the same therapeutic areas as Moberg Pharma.
AMGEN
AMGN
Mkt Cap160.66B
Amgen is a biotechnology company focused on developing novel treatments, some of which compete with Moberg Pharma's products.
Teva- Pharmaceutical Industries
TEVA
Mkt Cap23.49B
Teva Pharmaceutical Industries is a global leader in generic and specialty medicines, competing directly in some of the markets targeted by Moberg Pharma.

About

Pharmaceuticals: Other
Health Technology
Moberg Pharma AB (publ), a pharmaceutical company, develops and commercializes medical products primarily in Sweden. It offers MOB-015 for the treatment of nail fungus under the Terclara brand. The company was formerly known as Moberg Derma AB (publ) and changed its name to Moberg Pharma AB (publ) in May 2013. Moberg Pharma AB (publ) was incorporated in 2006 and is based in Bromma, Sweden.
Show more...
CEO
Anna Ljung
Country
SE
ISIN
SE0020353928

Listings

F
DE
MB8.F
ST
SE
MOB.ST
OTC Link
US
MBGPF

0 Comments

Share your thoughts

FAQ

What is Moberg Pharma AB stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange Moberg Pharma AB stocks are traded under the ticker MBGRF.
What were Moberg Pharma AB earnings last quarter?▼
MBGRF earnings for the last quarter are -0.04 USD per share, whereas the estimation was 0 USD resulting in a -∞% surprise. The estimated earnings for the next quarter are N/A USD per share.
Does Moberg Pharma AB pay dividends?▼
Yes, MBGRF dividends are paid en. The last dividend per share was 46.5 USD. As of today, Dividend Yield (FWD)% is 0%.
In which sector is Moberg Pharma AB located?▼
Moberg Pharma AB operates in the Healthcare sector.
When did Moberg Pharma AB complete a stock split?▼
Moberg Pharma AB has not had any recent stock splits.
Where is Moberg Pharma AB headquartered?▼
Moberg Pharma AB is headquartered in Bromma, SE.